@article{d20c53f539654c9cb355cdd47355fc68,
title = "GLP-1 receptor agonists in diabetic kidney disease",
author = "Michos, {Erin D.} and Tuttle, {Katherine R.}",
note = "Funding Information: K.R. Tuttle reports employment with Providence Health Care, University of Washington; consultancy agreements with AstraZe-neca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Goldfinch Bio, and Novo Nordisk; receiving research funding from Bayer and Goldfinch Bio; receiving honoraria from Bayer, Gilead, and Goldfinch Bio; and serving as a scientific advisor or member of CJASN, Kidney Health Initiative, Lancet Diabetes & Endocrinology, Nature Reviews Nephrology, and the National Institute of Diabetes and Digestive and Kidney Diseases. The remaining author has nothing to disclose.",
year = "2021",
month = oct,
doi = "10.2215/CJN.18771220",
language = "English (US)",
volume = "16",
pages = "1578--1580",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}